Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigid S Boland

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Scientific Reports|October 26, 2021
Case-control study of the association of chronic acid suppression and social determinants of health with COVID-19 infectionBing Zhang, Anna L Silverman, Saroja Bangaru, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2020
Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse CellsMarianne R Spalinger, Rong Hai, Jiang Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's DiseaseRobert Battat, Marjolijn Duijvestein, Niels Vande Casteele, et al.
Therapeutic Advances in Gastroenterology|November 26, 2020
Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's diseaseAriela K Holmer, Robert Battat, Parambir S Dulai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2023
HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysisVirginia Solitano, Antonio Facciorusso, Dermot P B McGovern, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 5, 2025
Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 GeneMarianne R Spalinger, Golshid Sanati, Pritha Chatterjee, et al.
The American Journal of Gastroenterology|January 30, 2019
Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsRobert Battat, Marjolijn Duijvestein, Leonardo Guizzetti, et al.
Analytical Chemistry|January 19, 2026
Quantitative Food Compounds Enable Dietary Ontology Referencing across 500 Foods and Human PlasmaJulius Agongo, Harsha Gouda, Aubreyana McMaugh, et al.
The FEBS Journal|February 1, 2020
Host engulfment pathway controls inflammation in inflammatory bowel diseaseIbrahim M Sayed, Katherine Suarez, Eileen Lim, et al.
Inflammatory Bowel Diseases|June 12, 2018
Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel DiseaseChristopher J Tyler, Tamara Pérez-Jeldres, Erik Ehinger, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Scientific Reports|October 26, 2021
Case-control study of the association of chronic acid suppression and social determinants of health with COVID-19 infectionBing Zhang, Anna L Silverman, Saroja Bangaru, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2020
Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse CellsMarianne R Spalinger, Rong Hai, Jiang Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's DiseaseRobert Battat, Marjolijn Duijvestein, Niels Vande Casteele, et al.
Therapeutic Advances in Gastroenterology|November 26, 2020
Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's diseaseAriela K Holmer, Robert Battat, Parambir S Dulai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2023
HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysisVirginia Solitano, Antonio Facciorusso, Dermot P B McGovern, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 5, 2025
Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 GeneMarianne R Spalinger, Golshid Sanati, Pritha Chatterjee, et al.
The American Journal of Gastroenterology|January 30, 2019
Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsRobert Battat, Marjolijn Duijvestein, Leonardo Guizzetti, et al.
Analytical Chemistry|January 19, 2026
Quantitative Food Compounds Enable Dietary Ontology Referencing across 500 Foods and Human PlasmaJulius Agongo, Harsha Gouda, Aubreyana McMaugh, et al.
The FEBS Journal|February 1, 2020
Host engulfment pathway controls inflammation in inflammatory bowel diseaseIbrahim M Sayed, Katherine Suarez, Eileen Lim, et al.
Inflammatory Bowel Diseases|June 12, 2018
Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel DiseaseChristopher J Tyler, Tamara Pérez-Jeldres, Erik Ehinger, et al.
Pageof 10